latest news in companies
Aquestive Therapeutics Faces Legal Scrutiny After FDA Flags Deficiencies in Anaphylm Application
Atlanta, Friday, 9 January 2026.
Aquestive Therapeutics is under investigation for potential securities violations following a nearly 40% stock plunge on January 9, 2026. The sharp decline occurred after the FDA identified deficiencies in the application for Anaphylm, the company’s severe allergy treatment, effectively stalling labeling discussions. With the critical January 31 approval deadline looming, multiple law firms are now examining whether the company misled investors regarding the drug’s regulatory viability.
Lawsuit Alleges EmblemHealth Blocked Mental Health Access Through Inaccurate Directories
New York, Friday, 9 January 2026.
The complaint accuses the insurer of inflating networks with unavailable providers—listing one psychiatrist 29 times—effectively denying New York City employees access to covered mental health treatment.
Investors Sue Fermi Inc. Over Alleged AI Campus Funding Fraud
San Diego, Friday, 9 January 2026.
Fermi shares plummeted 59% from their IPO price after the termination of a critical $150 million funding agreement, triggering a class action lawsuit alleging the company misled investors about AI campus demand.
Comstock Clears Final Regulatory Hurdle to Launch Industrial-Scale Solar Recycling Operations
Virginia City, Friday, 9 January 2026.
Securing its final permit today, Comstock Metals is set to commission a facility capable of recycling 3 million solar panels annually, creating a critical zero-landfill solution for the energy sector.
Atos Partners with World DanceSport Federation to Modernize Global Competitions
Paris, Friday, 9 January 2026.
Leveraging extensive major event experience, Atos joins the World DanceSport Federation to overhaul digital infrastructure, focusing on ticketing and data insights to elevate the global fan experience.
